MaxCyte (MXCT)
(Delayed Data from NSDQ)
$4.10 USD
-0.25 (-5.75%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.11 +0.01 (0.24%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.13 | 0.00% |
Earnings Summary
For their last quarter, MaxCyte (MXCT) reported earnings of -$0.09 per share, beating the Zacks Consensus Estimate of $-0.14 per share. This reflects a positive earnings surprise of 35.71%. Look out for MXCT's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.13 per share, reflecting a year-over-year decrease of 18.18%.
Earnings History
Price & Consensus
Zacks News for MXCT
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates
MXCT: What are Zacks experts saying now?
Zacks Private Portfolio Services